TWIST2-mediated chromatin remodeling promotes fusion-negative rhabdomyosarcomaAkansha M. Shah, Ning Liu, Rhonda Bassel‐Duby et al.|Science Advances|2023Cited by 13
CD73 contributes to the pathogenesis of fusion-negative rhabdomyosarcoma through the purinergic signaling pathwayKarla Cano Hernandez, Ning Liu, Akansha M. Shah et al.|Proceedings of the National Academy of Sciences|2024Cited by 9
Abstract 6193: TWIST2 promotes tumor progression and represses myogenic differentiation in rhabdomyosarcomaAkansha M. Shah, Ning Liu, Rhonda Bassel‐Duby et al.|Cancer Research|2022Cited by 0
Abstract 4750: TWIST2 mediated chromatin remodeling promotes fusion-negative rhabdomyosarcomaAkansha M. Shah, Ning Liu, Lei Guo et al.|Cancer Research|2023Cited by 0